Franco Cozzi

European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres

A. Silman, A. Gabrielli, S. Bombardieri, 2001, Annals of the rheumatic diseases.

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

F. Cacciapaglia, C. Campochiaro, G. de Luca, 2023, Journal of Translational Autoimmunity.

Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case–control study

M. Rizzo, L. Punzi, S. Cardarelli, 2013, Clinical Rheumatology.

Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.

F. Cacciapaglia, A. Della Rossa, C. Campochiaro, 2024, Journal of scleroderma and related disorders.

Evaluation of right ventricular function performed by 3D-echocardiography in scleroderma patients.

L. Badano, L. Punzi, F. Cozzi, 2015, Reumatismo.